Care of the Prostate Cancer Patient and Prospective Procurement of Prostate Cancer Tissue
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
Background: Prostate cancer is the most common noncutaneous cancer among men in the U.S. Researchers want to study blood, tissue, and fluid samples of people with prostate cancer. This will help them understand any changes in cells and genes. These changes might lead to the development and progression of prostate cancer. Researchers think the study could lead to new treatments. Objective: To understand the changes in cells and genes that lead to the development and progression of prostate cancer. This could lead to new treatments. Eligibility: Men ages 18 and older who have or are suspected to have prostate cancer Design: Participants will be screened with physical exam and medical history. Participants will send tissue blocks of their tumor, if possible. If not, they will provide unstained slides of tumor tissue. Participants may provide samples of blood, urine, saliva, and prostate secretions. Participants may have imaging tests. They will lie in a machine that takes pictures of their body. These tests include: MRI of the prostate CT of the abdomen and pelvis Chest x-ray Participants may need a biopsy or surgery for treatment of their cancer. If so, researchers will collect tissue. Participants may answer questions about their prostate cancer and quality of life. Participants may have follow-up visits or other treatments. They may have follow-up phone calls every few months. ...
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Mężczyźni w wieku 18 lat i więcej z potwierdzonym lub podejrzewanym rakiem prostaty
- •Muszą być gotowi poddać się badaniom diagnostycznym lub leczeniu
- •Muszą być w stanie wyrazić świadomą zgodę na uczestnictwo
- •Podwyższony poziom PSA (białka w prostaty) lub nieprawidłowe wyniki badania palcowego
- •Nieprawidłowy wynik badania MRI prostaty
- •Przypadki raka prostaty w rodzinie (ojciec lub brat) lub raka piersi/jajnika u bliskich krewnych (matka lub siostra)
✗ Disqualifies
- •Osoby, u których stan zdrowia uniemożliwia przeprowadzenie badań diagnostycznych lub leczenia
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- September 22, 2026
- Sex
- Male only
Locations (1)
National Institutes of Health Clinical Center
Bethesda, United States
Trial contact
Karen K Holcomb
Peter A Pinto, M.D.
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 9/1/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.